Literature DB >> 20678019

Update on the pathophysiology of liver fibrosis.

Massimo Pinzani1, Jose Macias-Barragan.   

Abstract

Fibrogenesis represents the main pathophysiological consequence of chronic liver disease and leads to life-threatening clinical consequences. The knowledge in this field has grown exponentially in the past 20 years and, currently, evaluation and treatment of liver fibrosis are central issues in hepatology. Classic mechanisms of liver fibrogenesis have been expanded and consolidated over the past few years. Concomitantly, novel mechanisms have been suggested and demonstrated. The aim of this article is to provide an update on these mechanisms with an attempt to integrate classic and novel pathways responsible for the evolution of the fibrogenic process and, potentially, for its regression.

Entities:  

Mesh:

Year:  2010        PMID: 20678019     DOI: 10.1586/egh.10.47

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  40 in total

1.  Clonorchis sinensis lysophospholipase inhibits TGF-β1-induced expression of pro-fibrogenic genes through attenuating the activations of Smad3, JNK2, and ERK1/2 in hepatic stellate cell line LX-2.

Authors:  Lina Zhou; Mei Shang; Mengchen Shi; Lu Zhao; Zhipeng Lin; Tingjin Chen; Yinjuan Wu; Zeli Tang; Hengchang Sun; Jinyun Yu; Yan Huang; Xinbing Yu
Journal:  Parasitol Res       Date:  2016-02       Impact factor: 2.289

2.  Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.

Authors:  F Sheedfar; M Vermeer; V Pazienza; J Villarroya; F Rappa; F Cappello; G Mazzoccoli; F Villarroya; H van der Molen; M H Hofker; D P Koonen; M Vinciguerra
Journal:  Int J Obes (Lond)       Date:  2014-05-21       Impact factor: 5.095

3.  Natural killer and natural killer T cells in liver fibrosis.

Authors:  Bin Gao; Svetlana Radaeva
Journal:  Biochim Biophys Acta       Date:  2012-09-26

Review 4.  RNA protein interactions governing expression of the most abundant protein in human body, type I collagen.

Authors:  Branko Stefanovic
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-05-28       Impact factor: 9.957

Review 5.  Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma.

Authors:  Miki Murata; Katsunori Yoshida; Takashi Yamaguchi; Koichi Matsuzaki
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

6.  Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury.

Authors:  Ingrid Lua; David James; Jiaohong Wang; Kasper S Wang; Kinji Asahina
Journal:  Hepatology       Date:  2014-04-28       Impact factor: 17.425

7.  Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells.

Authors:  Haitao Shi; Lei Dong; Xiaoyan Dang; Yaping Liu; Jiong Jiang; Yan Wang; Xiaolan Lu; Xiaoyan Guo
Journal:  Inflamm Res       Date:  2013-03-13       Impact factor: 4.575

8.  Cultured Mycelium Cordyceps sinensis allevi¬ates CCl4-induced liver inflammation and fibrosis in mice by activating hepatic natural killer cells.

Authors:  Yuan Peng; Kai Huang; Li Shen; Yan-yan Tao; Cheng-hai Liu
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

Review 9.  Bone marrow derived stem cells for the treatment of end-stage liver disease.

Authors:  Cristina Margini; Ranka Vukotic; Lucia Brodosi; Mauro Bernardi; Pietro Andreone
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

10.  Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators.

Authors:  Mardi M Algandaby; Ali M El-Halawany; Hossam M Abdallah; Abdulrahman M Alahdal; Ayman A Nagy; Osama M Ashour; Ashraf B Abdel-Naim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.